These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19392865)

  • 1. Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin.
    Sheridan DA; Price DA; Schmid ML; Toms GL; Donaldson P; Neely D; Bassendine MF
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1282-90. PubMed ID: 19392865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-alpha and ribavirin in HIV/HCV co-infected patients.
    Vargas A; Berenguer J; Catalán P; Miralles P; López JC; Cosín J; Resino S
    J Antimicrob Chemother; 2010 Feb; 65(2):303-6. PubMed ID: 20016018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C.
    Economou M; Milionis H; Filis S; Baltayiannis G; Christou L; Elisaf M; Tsianos E
    J Gastroenterol Hepatol; 2008 Apr; 23(4):586-91. PubMed ID: 17498221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.
    Gopal K; Johnson TC; Gopal S; Walfish A; Bang CT; Suwandhi P; Pena-Sahdala HN; Clain DJ; Bodenheimer HC; Min AD
    Hepatology; 2006 Aug; 44(2):335-40. PubMed ID: 16871569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner.
    Clark PJ; Thompson AJ; Vock DM; Kratz LE; Tolun AA; Muir AJ; McHutchison JG; Subramanian M; Millington DM; Kelley RI; Patel K
    Hepatology; 2012 Jul; 56(1):49-56. PubMed ID: 22318926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of lipid metabolism in patients with chronic viral hepatitis treated with interferon alpha].
    Zejc-Bajsarowicz M; Cieśla A; Mach T; Janas-Skulina U; Warunek W; Zyrkowska-Bieda T
    Przegl Lek; 2005; 62(4):214-7. PubMed ID: 16229237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemotactic protein-1 as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C.
    Gu B; Ye B; Mao WL; Ye JL
    Hepatogastroenterology; 2014; 61(129):55-8. PubMed ID: 24895793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.
    Younossi ZM; Stepanova M; Estep M; Negro F; Clark PJ; Hunt S; Song Q; Paulson M; Stamm LM; Brainard DM; Subramanian GM; McHutchison JG; Patel K
    J Hepatol; 2016 Jan; 64(1):29-36. PubMed ID: 26341824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.
    Mawatari H; Yoneda M; Fujita K; Nozaki Y; Shinohara Y; Sasaki H; Iida H; Takahashi H; Inamori M; Abe Y; Kobayashi N; Kubota K; Kirikoshi H; Nakajima A; Saito S
    J Viral Hepat; 2010 Apr; 17(4):274-9. PubMed ID: 19708862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.
    Scholtes C; Ramière C; Rainteau D; Perrin-Cocon L; Wolf C; Humbert L; Carreras M; Guironnet-Paquet A; Zoulim F; Bartenschlager R; Lotteau V; André P; Diaz O
    Hepatology; 2012 Jul; 56(1):39-48. PubMed ID: 22290760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.
    Mawatari H; Yoneda M; Fujita K; Nozaki Y; Shinohara Y; Sasaki H; Iida H; Takahashi H; Inamori M; Abe Y; Kobayashi N; Kubota K; Kirikoshi H; Nakajima A; Saito S
    J Viral Hepat; 2010 Dec; 17(12):859-65. PubMed ID: 20070501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.
    Fernández-Miranda C; Castellano G; Guijarro C; Fernández I; Schöebel N; Larumbe S; Gómez-Izquierdo T; del Palacio A
    Am J Gastroenterol; 1998 Oct; 93(10):1901-4. PubMed ID: 9772052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.
    Bridge SH; Sheridan DA; Felmlee DJ; Nielsen SU; Thomas HC; Taylor-Robinson SD; Neely RD; Toms GL; Bassendine MF
    Gut; 2011 May; 60(5):680-7. PubMed ID: 20940286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.